Skip to content

Study of patch test allergens

Multi center study of patch test allergens by the Japanese Contact Dermatitis Research Group

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs041210060
Enrollment
8000
Registered
2021-08-30
Start date
2021-08-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic contact dermatitis Contact dermatitis

Interventions

Patch testing with allergen (unapproved in Japan) to the patient of suspected contact dermatitis.
D010328
Patch test allergen

Sponsors

Yagami Akiko
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patient has skin disorder induced by any substances and products applied or contacted to the skin. 2) Patient who is willing to comply with the research implementation plan. 3) Patient have signed the consent form approved by the Ethics Review Committee of the Fujita Health University.

Exclusion criteria

Exclusion criteria: A patient whom a doctor judges that participation in research is inappropriate.

Design outcomes

Primary

MeasureTime frame
Survey analysis of positive rate of JBS, JBS2

Contacts

Public ContactNaoko Ishigaki

Fujita Health University Bantane Hospital

alergia@fujita-hu.ac.jp+81-52-321-8171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026